Helping patients with intermediate-risk thyroid cancer make decisions about radioactive iodine treatment
Official title: Use of a decision aid to resolve uncertainty about radioactive iodine treatment in patients with intermediate-risk thyroid cancer: the Radiance trial
Funded at Georgetown University · NIH-11225699 · Data updated 2026-11-12
This study is here to help people with intermediate-risk thyroid cancer understand the pros and cons of using radioactive iodine treatment after surgery, so they can make informed choices about their care.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Georgetown University NIH-funded |
| Lab location | 1 site (Washington, United States) |
| Project start | September 5, 2022 |
| Project end | January 31, 2030 |
| Funding year | 2025 |
| Award (this year) | $767,922 |
| NIH project number | 4UH3DE031248-03 |
| Project ID | NIH-11225699 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with intermediate-risk differentiated thyroid cancer who are considering treatment options.
✕Less likely to help
Patients with low-risk or high-risk differentiated thyroid cancer may not benefit from this research.
What this research studies
This research aims to assist patients diagnosed with intermediate-risk differentiated thyroid cancer in understanding the risks and benefits of radioactive iodine (RAI) treatment. It addresses the uncertainty many patients face when deciding between surgery alone or surgery combined with RAI, which can have significant side effects. The study will utilize a decision aid to provide clear information about potential outcomes, side effects, and quality of life impacts associated with RAI. By focusing on patient-centered decision-making, the research seeks to empower individuals to make informed choices regarding their treatment options.
Why it matters
Potential benefit: If successful, this research could lead to better-informed treatment decisions and improved quality of life for patients with intermediate-risk thyroid cancer.
How similar studies have gone: Previous research has shown that decision aids can effectively improve patient understanding and satisfaction in treatment choices, indicating a promising approach in this context.
Where this research is happening
-
Georgetown University
Washington, United States Active
Researchers
- Principal investigator: Jonklaas, Jacqueline — Georgetown University
- Study coordinator: Jonklaas, Jacqueline
Related research
Other NIH-funded projects on the same topics.
-
WTC Dust and Thyroid Cancer Progression in Human Organoids
This grant tests how World Trade Center dust might influence thyroid cancer progression using human thyroid organoids to model real-life exposure.
-
Integrating molecular signals to guide thyroid cancer care
A doctor-scientist team at Brigham and Women’s Hospital is studying how tumor biology and the immune environment can guide personalized monitoring and treatment for differentiated thyroid cancer.
-
Metabolic Imaging to Track Treatment Response in Aggressive Thyroid Cancer
This grant explores a new way to watch how aggressive thyroid cancers respond to treatment using a special MRI technique that tracks tumor metabolism.
-
Adoptive T-cell Therapy for Anaplastic Thyroid Cancer
A patient-focused program explores using patient immune cells engineered to target and fight anaplastic thyroid cancer, especially for those whose cancer has stopped responding to standard treatments.
-
Overcoming Resistance to BRAF Inhibitors in Aggressive Thyroid Cancers
A patient-focused research effort to find new ways to treat difficult thyroid cancers that no longer respond to current BRAF inhibitors.
-
Improving Treatment of Anaplastic Thyroid Cancer with New Therapies and Early Response Checks
This NIH grant aims to advance treatment for a rare, aggressive thyroid cancer by testing new approaches and measuring how tumors respond early in treatment to tailor care.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.